• 1091 Citations
  • 19 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giuseppe Lombardi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

temozolomide Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
fotemustine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Glioma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Pituitary Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 1091 Citations
  • 19 h-Index
  • 95 Article
  • 2 Letter
  • 2 Review article
  • 1 Editorial

Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma

Zoccarato, M., Valeggia, S., Zuliani, L., Gastaldi, M., Mariotto, S., Franciotta, D., Ferrari, S., Lombardi, G., Zagonel, V., De Gaspari, P., Ermani, M., Signori, A., Pichiecchio, A., Giometto, B. & Manara, R., Aug 26 2019, In : Neuroradiology. 60, p. 853-60 7 p.

Research output: Contribution to journalArticle

Limbic Encephalitis
Glioma
Magnetic Resonance Imaging
Brain
Neoplasms

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Lombardi, G., De Salvo, G. L., Brandes, A. A., Eoli, M., Rudà, R., Faedi, M., Lolli, I., Pace, A., Daniele, B., Pasqualetti, F., Rizzato, S., Bellu, L., Pambuku, A., Farina, M., Magni, G., Indraccolo, S., Gardiman, M. P., Soffietti, R. & Zagonel, V., Jan 2019, In : The Lancet. Oncology. 20, 1, p. 110-119 10 p.

Research output: Contribution to journalArticle

Lomustine
Glioblastoma
Survival
temozolomide
Italy

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

Brandes, A. A., Gil-Gil, M., Saran, F., Carpentier, A. F., Nowak, A. K., Mason, W., Zagonel, V., Dubois, F., Finocchiaro, G., Fountzilas, G., Cernea, D. M., Chinot, O., Anghel, R., Ghiringhelli, F., Beauchesne, P., Lombardi, G., Franceschi, E., Makrutzki, M., Mpofu, C., Urban, H-J. & 1 others, Pichler, J., Sep 28 2018, In : The oncologist.

Research output: Contribution to journalArticle

Glioblastoma
Lomustine
Safety
temozolomide
Placebos

Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed Administration

Pasqualetti, F., Gonnelli, A., Molinari, A., Cantarella, M., Montrone, S., Cristaudo, A., Baldaccini, D., Mattioni, R., Delishaj, D., Mazzotti, V., Morganti, R., Cocuzza, P., Fabrini, M. G., Lombardi, G., Rudà, R., Soffietti, R. & Paiar, F., Oct 2018, In : Anticancer Research. 38, 10, p. 5877-5881 5 p.

Research output: Contribution to journalArticle

Glioblastoma
Recurrence
Disease-Free Survival
Bevacizumab
Survival

Discordance of IDH mutational status between lesions in an adult patient with multifocal glioma

Lombardi, G., Puppa, A. D., Gardiman, M. P., Rossi, S., Candiotto, C., Zanatta, L., Bertorelle, R., De Rossi, A., Fassan, M. & Zagonel, V., Jul 5 2018, In : Neuro-Oncology. 20, 8, p. 1142-1143 2 p.

Research output: Contribution to journalLetter